U-Blot® Research Grade TarextumabCat. No. WA3616Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TarextumabCat. No. WA3616
U-Blot® Research Grade TarcocimabCat. No. WA3615
U-Blot® Research Grade TaplitumomabCat. No. WA3614
U-Blot® Research Grade tanruprubartCat. No. WA3613
U-Blot® Research Grade TanibirumabCat. No. WA3612
U-Blot® Research Grade TanfanerceptCat. No. WA3611
U-Blot® Research Grade TanezumabCat. No. WA3610
U-Blot® Research Grade TamtuvetmabCat. No. WA3609
U-Blot® Research Grade TamrintamabCat. No. WA3608
U-Blot® Research Grade TamgiblimabCat. No. WA3607
U-Blot® Research Grade tambotatugCat. No. WA3606
U-Blot® Research Grade TalquetamabCat. No. WA3605